The Year in Cardio-oncology 2022

Cardiovascular disease and cancer are the leading causes of death worldwide. With advent of novel and improved cancer therapies, a growing population of cancer patients with cardiac complications is seen. Taking this into consideration, the clinical studies have also shifted their focus from the study of a single disease to the interdisciplinary study of oncology and cardiology. This current review article provides a comprehensive review of all major articles and guidelines from the year 2021-2022 in the field of cardio-oncology. (Curr Probl Cardiol 2023;48:101435.)

Automated summary

Cardiovascular disease and cancer are leading causes of global mortality. As novel cancer therapies continue to emerge, there is an increasing population of cancer patients with cardiac complications. Accordingly, clinical studies have shifted focus towards the interdisciplinary study of oncology and cardiology. This review article provides a comprehensive overview of major articles and guidelines in the field of cardio-oncology from 2021-2022.